CanadaJAMP SERTRALINE 50mg capsules (DIN 02469634), lot H242490 from JAMP Pharma Corporation may contain Sertraline 25mg capsules. Verify if your product is affected; consult your healthcare provider before discontinuing use, contact the recalling firm with any questions, and report any side effects or other health product safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: JAMP Pharma Corporation, 1310 Rue Nobel,, Boucherville, QC,, J4B 5H3.
How to identify it
Brand: JAMP; Product Name: JAMP-Setraline; Market Authorization: DIN 02469634; Dosage Form: Capsules; Strength: SERTRALINE (SERTRALINE HYDROCHLORIDE) 50mg; Lot: H242490
The hazard
The affected lot (Sertraline 50mg) may contain Sertraline 25mg capsules.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)